People · Operator
Named in public records as an officer, director or promoter · active 2013–2024 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| RealBio Technology, Inc. | — | Biotechnology | Seed | $3.1M | $21.5M | 2013 |
| Renova Therapeutics, Inc. | — | Biotechnology | Pre-Seed | $167K | $739K | 2024 |
Roy Cosan at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Roy Cosan on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jack Ball | 1 | 10 |
| Michael Torres | 1 | 5 |
| Patrick G. Morand | 1 | 4 |
| William Davidson | 1 | 2 |
| Shawn Swaney | 1 | 2 |
| Paul Neeb | 1 | 2 |
| John Trittschuh | 1 | 1 |
| Pierre Lecocq | 1 | 1 |
| Vijay Mahant | 1 | 1 |
| Kirk Hammond | 1 | 1 |
| Morgan Xu | 1 | 1 |
| Gene McKay | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.